Lysophosphatidylinositol (LPI) Research Dashboard
What am I missing as a non-subscriber?
To see a full dashboard with study details and filtering, go to our DEMO page.
As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.
CannaKeys has 30 studies associated with Lysophosphatidylinositol (LPI).
Here is a small sampling of Lysophosphatidylinositol (LPI) studies by title:
- The oncogenic lysophosphatidylinositol (LPI)/GPR55 signaling
- Lysophosphatidylinositol: a novel link between ABC transporters and G-protein-coupled receptors
- Expression of Lysophosphatidylinositol Signaling-relevant Molecules in Colorectal Cancer
- Novel Knowledge-Based Transcriptomic Profiling of Lipid Lysophosphatidylinositol-Induced Endothelial Cell Activation
- Interactions between lysophosphatidylinositol receptor GPR55 and sphingosine-1-phosphate receptor S1P5 in live cells
Ready to become a subscriber? Go to our PRICING page. Want to learn more about Endocannabinoid Medicine? Buy a book.
Endocannabinoid Medicine: 11 Keys to Deeper Healing
A clear, science-based guide to working with the endocannabinoid system for whole-body balance.
Buy Book
Cannabis for Chronic Pain Relief: A Dual Guide for Patients and Clinicians
A practical, evidence-based guide to using cannabis and cannabinoids for chronic pain.
Buy BookPage Quick Links
Select New Cannabinoid
Overview - Lysophosphatidylinositol (LPI)
Description of Lysophosphatidylinositol (LPI)
Lysophosphatidylinositol (LPI) is a bioactive lipid produced by the phospholipase A (PLA) family of lipases. LPI is posited to play a significant role in diverse physiological and pathological processes.
LPI is a proposed endogenous ligand/agonist for GPR55 (Roberto Piñeiro et al. 2012)
2-arachidonoyl lysophosphatidylinositol (2-ALPI)
2-LPI is a proposed endogenous ligand/agonist for GPR55 (Saori Oka et al. 2009)
Other Names:
LysophosphatidylinositolLPI: L-alpha-lysophosphatidylinositol; L-α-lysophosphatidylinositol
LPI IUPAC Name: [(2S)-2-hydroxy-3-[hydroxy-[(2R,3S,5R,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] acetate
LPI Molecular Formula: C11H21O12P
2-ALPI: 2-arachidonoyl-LPI; 2-arachidonoyl-lysophosphatidylinositol; 2-arachidonoyl-sn-glycero-3-phospho-D-myo-inositol 4,5-bisphosphate
2-ALPI IUPAC Name: [(1R,2S,3R,4R,5S,6R)-2,3,5-trihydroxy-4-[[(2R)-3-hydroxy-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]-oxidophosphoryl]oxy-6-phosphonatooxycyclohexyl] phosphate
2-ALPI Molecular Formula: C29H46O18P3-5
Source–PubChem
Lysophosphatidylinositol (LPI) Properties and Effects
Only Members can view Properties and Effects information. See DEMO page.
Lysophosphatidylinositol (LPI) Receptor Binding
Only Members can view Receptor Binding information. See DEMO page.
Disclaimer
Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own licensed physician or other medical professional. You
should not use the information contained herein for diagnosing or treating a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a
medical problem, promptly contact your health care provider.
Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.
